Clinical Trial Update: Ozone Plasma on Lung Function and Inflammatory Parameters in Pulmonary Sequelae Associated With Coronavirus 19 Infection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring ozone plasma therapy on lung function and inflammatory parameters in pulmonary sequelae after COVID-19 infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Sequelae After COVID-19

Drugs mentioned

• Ozone plasma therapy

Snippet

Sponsor: Centro Universitario de Ciencias de la Salud, Mexico | Conditions: COVID-19 | Phase 2 | Status: UNKNOWN